Minerva Neuroscie (NERV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,640 | 480 | 0 | N/A | 0 |
| TOTAL | $24,223 | $513 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 34,236 | 34,227 | N/A | N/A | N/A |
| Intangibles | 14,869 | 15,104 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 3,112 | 0 | 0 | 0 |
| TOTAL | $49,105 | $52,443 | $N/A | $N/A | $N/A |
| Total Assets | $73,328 | $52,956 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,008 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 942 | 5,708 | 0 | 0 | 0 |
| Accrued Expenses | 2,237 | 2,339 | 0 | N/A | 0 |
| TOTAL | $3,179 | $10,054 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| TOTAL | $13,434 | $13,669 | $N/A | $N/A | $N/A |
| Total Liabilities | $16,613 | $23,722 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,305 | 2,305 | 682 | N/A | N/A |
| Common Shares | 2 | 1 | 0 | N/A | 0 |
| Retained earnings | -67,289 | -40,134 | 0 | N/A | 0 |
| TOTAL | $56,715 | $29,234 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $73,328 | $52,956 | $0 | $0 | $0 |